StockData
NovaBridge Biosciences logo

NovaBridge Biosciences (NBP) stock

NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 0/30
$0.90+0.08 (+9.83%)

Close on Nov 18, 2026Market cap $104.20MP/E –Yield –

NovaBridge Biosciences net income

Net income is the profit left for shareholders after every expense, interest and tax.

NovaBridge Biosciences's net income for the twelve months ending Dec 31, 2020 was CN¥470.92M. For fiscal 2023 it was -CN¥1.47B. The highest annual figure on record is CN¥470.92M in fiscal 2020.

Annual net income

PeriodPeriod endValueChange
FY2023Dec 31, 2023-CN¥1.47B–
FY2022Dec 31, 2022-CN¥2.51B–
FY2021Dec 31, 2021-CN¥2.33B-595.1%
FY2020Dec 31, 2020CN¥470.92M–
FY2019Dec 31, 2019-CN¥1.45B–
FY2018Dec 31, 2018-CN¥402.83M–
FY2017Dec 31, 2017-CN¥298.24M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2020Dec 31, 2020CN¥1.04B–
Q4 FY2019Dec 31, 2019-CN¥348.57M–

More NovaBridge Biosciences figures

See a number that looks wrong?